Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VICS for Painful Vertebral Metastases
NCT00374751Phase 2Completed
- Sponsor
- NewYork-Presbyterian Brooklyn Methodist Hospital
- Start
- May 2006
- Primary completion
- Jan 2014
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
A Phase 2 trial of samarium-153 in bone metastasis, cancer pain, sponsored by NewYork-Presbyterian Brooklyn Methodist Hospital. Started May 2006; status: completed.
02
Drugs
samarium-153
03
Conditions
bone metastasiscancer pain
Beyond the preview
Go deeper on NCT00374751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00374751.